Vinva Investment Management Ltd Purchases 50,206 Shares of Merck & Co., Inc. $MRK - MarketBeat

Rathbones Group PLC Has $34.35 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat

Heritage Wealth Advisors Acquires 24,697 Shares of Merck & Co., Inc. $MRK - MarketBeat

Natixis Advisors LLC Has $193.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Korea Investment CORP Sells 198,111 Shares of Merck & Co., Inc. $MRK - MarketBeat

Modern Wealth Management LLC Has $2.83 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Shares Acquired by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat

Blair William & Co. IL Has $68.18 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

This week dividends rotation

Biotech CEOs should do their own version of the fast food CEOs trying their products

Munich Reinsurance Co Stock Corp in Munich Takes Position in Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Position Trimmed by HUB Investment Partners LLC - MarketBeat

Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine - Insider Monkey

Merck & Co., Inc. $MRK Shares Acquired by DKRT Investments Corp. - MarketBeat

Merck KGaA XTRA MRK Margin Decline Challenges Bullish Profitability Narratives - simplywall.st

Assessing Merck KGaA (XTRA:MRK) Valuation After Recent Share Price Weakness - Yahoo Finance

Stock Mid Term Trades

Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd - MarketBeat

Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat

GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA - MarketBeat

Assessing Merck KGaA (XTRA:MRK) Valuation After Latest Earnings And Life Science Growth - simplywall.st

8 months into dividend investment, how's my strategy?

AI-Powered Tempus Inks New Multi-Year Merck Deal - Yahoo Finance Singapore

Cas and effect: Merck’s phase III ripples HIF-2α space - bioworld.com

Patent Cliff + 10% FCF Yield. Is this a Value Trap?

Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance

J.P. Morgan Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $125 - 富途牛牛

Assessing Merck (MRK) Valuation As Recent Share Price Strength Meets Conflicting Fair Value Views - Yahoo Finance

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

Assessing Merck (MRK) Valuation As Recent Share Price Momentum Draws Fresh Attention - simplywall.st

Merck (MRK) Stock; Up After Volatile Session Despite Revenue Forecast Miss - CoinCentral

MRK Holdings Stock Hits Day Low of JPY 129 Amid Price Pressure - Markets Mojo

Merck begins construction of $3 billion manufacturing facility in Virginia - AOL.com

Merck KGaA sees earnings drop on currency effects, MS drug - Reuters

My Official $SCHD Q1 Payout Estimate drops later today! 💰 Before I reveal it… what do you think $SCHD Q1 dividend growth will come in at? Here’s all the raises and cuts we’re working with right now👇 $SCHD Q1 2026 Dividend Growth Update As of Mar 4, 2026 EX DIVIDEND: 3/25 PA

Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat

Prospects for Merck & Co’s DOR/ISL in HIV - The Pharma Letter

Takeda aims at Bristol and Merck | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Merck’s KEYTRUDA Combo Wins and Pipeline Shuffle Might Change The Case For Investing In Merck (MRK) - Yahoo Finance

MRK Stock Today: Japan HPV 9‑Valent Uptake Signals Demand Tailwind — March 04 - Meyka

MRK.DE down 3.9% to €121.35 on XETRA as 05 Mar 2026 earnings loom: key catalysts - Meyka

Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.4% - Should You Sell? - MarketBeat

Merck & Co. Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

MRK: Transforming to a diversified, innovation-driven portfolio with robust late-stage pipeline assets - TradingView

Merck Is Up 42% in the Last 6 Months. Here’s Where the Stock Could Head in 2026 - TIKR.com

AI-Powered Tempus Inks New Multi-Year Merck Deal - Tempus AI (NASDAQ:TEM) - Benzinga

Pre-market 04 Mar 2026: MRK (9980.T JPX) vol 7.23M, JPY 129.00: monitor momentum - Meyka

Merck & Co. Stock Hits Day High with Strong Intraday Performance - Markets Mojo

Merck & Co. picks Tempus' AI models for new oncology data deal - FirstWord Pharma

Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future - simplywall.st

Merck (MRK) Partners with Tempus AI for Precision Oncology Advan - GuruFocus

Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha

Merck Stock: Why Expect a 50% Upside After the $70 Billion Pipeline Disclosure - TIKR.com

Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead? - TradingView

2026 ASCO GU Update

Merck (MRK) Enhances Collaboration with TempusAI for Precision M - GuruFocus

Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

CDC acting director calls for measles vaccination (MRK:NYSE) - Seeking Alpha

I took 547 stock recommendations from r/ValueInvesting and had AI grade every single one

Miramar Capital LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Laurel Wealth Advisors LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Merck advances Welireg into earlier-stage kidney cancer with Phase III win - The Pharma Letter

MXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0 - Yahoo Finance UK

Merck & Co., Inc. (NYSE:MRK) Shares Down 1.9% - Here's What Happened - MarketBeat

Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? - Finviz

Layoff Tracker: Cuts at Merck, Disc Leave Hundreds Jobless

Merck to wind down Gardasil production at N.C. plant, lay off 150-plus

A Merck cancer drug to watch - statnews.com

Wells Fargo Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $135 - 富途牛牛

Merck, Pfizer’s Drug Combo ‘Rewrites the Standard of Care’ in Bladder Cancer - BioSpace

ESGO 2026 – regulators don’t buy Merck’s all-comers claim | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Merck & Co., Inc. $MRK Position Lifted by Kingsview Wealth Management LLC - MarketBeat

Leerink raises Merck stock price target on belzutifan growth - Investing.com

Elo Mutual Pension Insurance Co Has $24.19 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Titan with Strong Buy Ratings and Growth Potential - DirectorsTalk Interviews

Fisher Asset Management LLC Sells 945,571 Shares of Merck & Co., Inc. $MRK - MarketBeat

Merck (MRK) PT Raised to $129 at Leerink Partners - StreetInsider

Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

Merck stock forecast for 2030: Can division overhaul and late-stage surge push MRK to $180? - Traders Union

Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK - MarketBeat

Merck & Co.'s Welireg bags priority FDA review in early RCC with pivotal DFS data - FirstWord Pharma

Merck (MRK) Stock Dips While Market Gains: Key Facts - Bitget

Merck announces $3 billion small-molecule plant expansion in Elkton, virginia - Virginia Business

Merck stock heads into Monday with Keytruda, Welireg cancer data and FDA review dates on deck - TechStock²

Merck (MRK) and Eisai Share Promising Phase 3 Trial Results for Kidney Cancer Treatment - GuruFocus

Merck (MRK) Presents Promising Phase 3 Trial Results for Keytrud - GuruFocus

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

River Wealth Advisors LLC Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Shares Bought by Rafferty Asset Management LLC - MarketBeat

Quantbot Technologies LP Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Bedell Frazier Investment Counselling LLC Sells 34,557 Shares of Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Shares Sold by Diversify Wealth Management LLC - MarketBeat

APG Asset Management N.V. Sells 120,916 Shares of Merck & Co., Inc. $MRK - MarketBeat

MRK Stock Quote Price and Forecast - CNN

MRK SEC Filings - Merck & Co 10-K, 10-Q, 8-K Forms - Stock Titan